Twist Bioscience signals $123M-$124M Q4 revenue as fiscal 2026 outlook rises to $456M-$457M

Twist Bioscience (TWST) Q3 FY2026 earnings call: record revenue, raised FY2026 guidance, and AI drug discovery growth outlook—read key takeaways now.